User profiles for George Miles
George A. MilesBeinecke Rare Book Library, Yale University Verified email at yale.edu Cited by 675 |
[BOOK][B] Under an open sky: rethinking America's Western past
W Cronon, GA Miles, J Gitlin - 1993 - books.google.com
The history of the American West is being transformed by exciting new ideas, new questions,
new scholarship. For many years this field was dominated by popular images of the lone …
new scholarship. For many years this field was dominated by popular images of the lone …
[PDF][PDF] Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
…, M Wiznerowicz, S Satpathy, MA Gillette, G Miles… - Cancer cell, 2021 - cell.com
We present a proteogenomic study of 108 human papilloma virus (HPV)-negative head and
neck squamous cell carcinomas (HNSCCs). Proteomic analysis systematically catalogs …
neck squamous cell carcinomas (HNSCCs). Proteomic analysis systematically catalogs …
[PDF][PDF] Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy
The integration of mass spectrometry-based proteomics with next-generation DNA and RNA
sequencing profiles tumors more comprehensively. Here this "proteogenomics" approach …
sequencing profiles tumors more comprehensively. Here this "proteogenomics" approach …
[PDF][PDF] Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
…, DW Young, A Malovannaya, F Stossi, G Miles… - Cell, 2021 - cell.com
Many oncogenic insults deregulate RNA splicing, often leading to hypersensitivity of tumors
to spliceosome-targeted therapies (STTs). However, the mechanisms by which STTs …
to spliceosome-targeted therapies (STTs). However, the mechanisms by which STTs …
Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer
…, MA Gillette, B Zhang, GV Echeverria, G Miles… - Cancer discovery, 2022 - AACR
Proteogenomic analysis of triple-negative breast tumors revealed a complex landscape of
chemotherapy response associations, including a 19q13.31–33 somatic deletion encoding …
chemotherapy response associations, including a 19q13.31–33 somatic deletion encoding …
Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore
G Miles, L Movileanu, H Bayley - Protein Science, 2002 - Wiley Online Library
Staphylococcal leukocidin pores are formed by the obligatory interaction of two distinct
polypeptides, one of class F and one of class S, making them unique in the family of β‐barrel pore…
polypeptides, one of class F and one of class S, making them unique in the family of β‐barrel pore…
Hemodynamic predictors of mortality in adults with sickle cell disease
…, X Tian, MJ Cuttica, CF Barnett, G Miles… - American journal of …, 2013 - atsjournals.org
Background: Pulmonary hypertension (PH) in adults with sickle cell disease (SCD) is
associated with early mortality, but no prior studies have evaluated quantitative relationships of …
associated with early mortality, but no prior studies have evaluated quantitative relationships of …
[HTML][HTML] Microscaled proteogenomic methods for precision oncology
Cancer proteogenomics promises new insights into cancer biology and treatment efficacy by
integrating genomics, transcriptomics and protein profiling including modifications by mass …
integrating genomics, transcriptomics and protein profiling including modifications by mass …
Byzantium and the Arabs: relations in Crete and the Aegean area
GC Miles - Dumbarton Oaks Papers, 1964 - JSTOR
This paper, written for oral presentation, was read at the Symposium on" The Relations
between Byzantium and the Arabs" at Dumbarton Oaks in May 1963. It is reproduced here …
between Byzantium and the Arabs" at Dumbarton Oaks in May 1963. It is reproduced here …
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Despite substantial advances in targeting mutant KRAS, tumor resistance to KRAS inhibitors
(KRASi) remains a major barrier to progress. Here, we report proteostasis reprogramming …
(KRASi) remains a major barrier to progress. Here, we report proteostasis reprogramming …